Published: 2024-02-29   No 6 Date of announcement 2024/02/29 Time of announcement 18:05:59 Subject Announcement for the change of the Company’s Spokesperson Date of events 2024/02/29 To which item it meets paragraph 8 Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance...Read More

Published: 2024-02-29   No 7 Date of announcement 2024/02/29 Time of announcement 18:06:16 Subject Announcement for the change of the Company’s Chief Internal Auditor Date of events 2024/02/29 To which item it meets paragraph 8 Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer,...Read More

Published: 2024-02-29   No 5 Date of announcement 2024/02/29 Time of announcement 18:05:44 Subject Announcement for the change of the Company’s General Manager. Date of events 2024/02/29 To which item it meets paragraph 6 Date of the board of directors resolution or date of occurrence of the change:2024/02/29 Position (Please enter chairperson or president/general manager):...Read More

Published: 2024-02-29   No 2 Date of announcement 2024/02/29 Time of announcement 17:31:22 Subject The Board of Directors resolved not to distribute dividends. Date of events 2024/02/29 To which item it meets paragraph 17 Date of the board of directors resolution :2024/02/29 Year or quarter which dividends belong to:2023 Period which dividends belong to:2023/01/01~2023/12/31 Appropriations...Read More

Published: 2024-02-29   No 3 Date of announcement 2024/02/29 Time of announcement 17:33:08 Subject The Company’s 2023 financial statements have been approved by the Board of Directors Date of events 2024/02/29 To which item it meets paragraph 31 Date of submission to the board of directors or approval by the board of directors:2024/02/29 Date of...Read More

Published: 2024-02-22 February 22, 2024 12:13 PM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Rejuvenate Bio today announced publication of groundbreaking research in the peer-reviewed journal Cellular Reprogramming. The study, titled “Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice,” reveals promising advancements in combating age-related diseases and extending lifespan through cellular rejuvenation....Read More

Published: 2024-02-19 Author: Danny Sullivan | Published on: February 19, 2024 | Last updated: February 19, 2024 Longevity biotech company Rejuvenate Bio has revealed a strategic partnership to advance the development and commercialization of its gene therapy designed to address canine osteoarthritis. The collaboration with an unnamed “global animal health company” aims to combat the...Read More

Published: 2024-02-07   No 1 Date of announcement 2024/02/07 Time of announcement 11:05:29 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2024/02/07 To which item it meets paragraph 51 Date of occurrence...Read More

Published: 2024-01-08   No 2 Date of announcement 2024/01/08 Time of announcement 17:49:02 Subject Announcement for the Company’s commitments made when applying for listing of stock and its subsequent implementation. Date of events 2024/01/08 To which item it meets paragraph 51 1. Date of occurrence of the event:2024/01/08 2. Company name:Diamond Biofund Inc. 3. Relationship...Read More

Published: 2024-01-08   No 1 Date of announcement 2024/01/08 Time of announcement 17:48:45 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2024/01/08 To which item it meets paragraph 51 Date of occurrence...Read More